The DOI matches its Crossref record; 608 of the 608 references it cites were found in a registry or an index.
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Open accessAbstract
Glycoconjugates are major constituents of mammalian cells that are formed via covalent conjugation of carbohydrates to other biomolecules like proteins and lipids and often expressed on the cell surfaces. Among the three major classes of glycoconjugates, proteoglycans and glycoproteins contain glycans linked to the protein backbone via amino acid residues such as Asn for N -linked glycans and Ser/Thr for O -linked glycans. In glycolipids, glycans are linked to a lipid component such as glycerol, polyisoprenyl pyrophosphate, fatty acid ester, or sphingolipid. Recently, glycoconjugates have become better structurally defined and biosynthetically understood, especially those associated with human diseases, and are accessible to new drug, diagnostic, and therapeutic developments. This review describes the status and new advances in the biological study and therapeutic applications of natural and synthetic glycoconjugates, including proteoglycans, glycoproteins, and glycolipids. The scope, limitations, and novel methodologies in the synthesis and clinical development of glycoconjugates including vaccines, glyco-remodeled antibodies, glycan-based adjuvants, glycan-specific receptor-mediated drug delivery platforms, etc ., and their future prospectus are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 608
Engineering of glycosidases and glycosyltransferases
Hancock, S. M., Vaughan, M. D., & Withers, S. G. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.07.015 · Cited by 291
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Huang, Y. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2016.12.003 · Cited by 291
Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
Milewska, A., Zarebski, M., Nowak, P., Stozek, K., Potempa, J., & Pyrc, K. (2014) · Journal of Virology · doi:10.1128/jvi.02078-14 · Cited by 289
Glycolipid Antigen Processing for Presentation by CD1d Molecules
Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T., Koezuka, Y., Kulkarni, A., & Kronenberg, M. (2001) · Science · doi:10.1126/science.291.5504.664 · Cited by 287
Wang, S.-K., Liang, P.-H., Astronomo, R. D., Hsu, T.-L., Hsieh, S.-L., Burton, D. R., & Wong, C.-H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712326105 · Cited by 287
Self-citationTumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy
Yoon, H. Y., Koo, H., Choi, K. Y., Lee, S. J., Kim, K., Kwon, I. C., Leary, J. F., Park, K., Yuk, S. H., Park, J. H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.016 · Cited by 284
Enzymes in the Synthesis of Glycoconjugates
Schmaltz, R. M., Hanson, S. R., & Wong, C.-H. (2011) · Chemical Reviews · doi:10.1021/cr200113w · Cited by 283
Self-citationO’Hagan, D. T. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.699 · Cited by 282
van Geel, R., Wijdeven, M. A., Heesbeen, R., Verkade, J. M. M., Wasiel, A. A., van Berkel, S. S., & van Delft, F. L. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00224 · Cited by 279
Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.
Ulrich, J. T., & Myers, K. R. (1995) · PubMed · Cited by 278
Chemical Synthesis of Glycosaminoglycans
Mende, M., Bednarek, C., Wawryszyn, M., Sauter, P., Biskup, M. B., Schepers, U., & Bräse, S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00010 · Cited by 277
Kinoshita, T., & Fujita, M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r063313 · Cited by 273
Role of protein glycosylation in cancer metastasis
Oliveira-Ferrer, L., Legler, K., & Milde-Langosch, K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.002 · Cited by 273
Glycointeractions in bacterial pathogenesis
Poole, J., Day, C. J., von Itzstein, M., Paton, J. C., & Jennings, M. P. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0007-2 · Cited by 271
Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering
Nielsen, J. (2013) · Bioengineered · doi:10.4161/bioe.22856 · Cited by 270
Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
Jacobs, P. P., Geysens, S., Vervecken, W., Contreras, R., & Callewaert, N. (2009) · Nature Protocols · doi:10.1038/nprot.2008.213 · Cited by 270
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
Pancera, M., Shahzad-ul-Hussan, S., Doria-Rose, N. A., McLellan, J. S., Bailer, R. T., Dai, K., Loesgen, S., Louder, M. K., Staupe, R. P., Yang, Y., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2600 · Cited by 270
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Quast, I., Keller, C. W., Maurer, M. A., Giddens, J. P., Tackenberg, B., Wang, L.-X., Münz, C., Nimmerjahn, F., Dalakas, M. C., & Lünemann, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82695 · Cited by 269
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
Pifferi, C., Fuentes, R., & Fernández-Tejada, A. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-020-00244-3 · Cited by 265
Heparan sulfate proteoglycans in invasion and metastasis
Sanderson, R. D. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0241 · Cited by 262
Marcos, N. T., Pinho, S., Grandela, C., Cruz, A., Samyn-Petit, B., Harduin-Lepers, A., Almeida, R., Silva, F., Morais, V., Costa, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1921 · Cited by 258
[Chondroitin sulfate proteoglycans in neural development and regeneration].
Gu, W.-L., & Lu, P. (2007) · PubMed · Cited by 255
Influenza Hemagglutinin Structures and Antibody Recognition
Wu, N. C., & Wilson, I. A. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038778 · Cited by 251
Chemoenzymatic Methods for the Synthesis of Glycoproteins
Li, C., & Wang, L.-X. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00238 · Cited by 250
Erythropoietins: A common mechanism of action
Elliott, S., Pham, E., & Macdougall, I. C. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.08.003 · Cited by 246
Location, location, location: new insights into O-GalNAc protein glycosylation
Gill, D. J., Clausen, H., & Bard, F. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.11.004 · Cited by 246
The Role of Carbohydrate in Erythropoietin Action*
DORDAL, M. S., WANG, F. F., & GOLDWASSER, E. (1985) · Endocrinology · doi:10.1210/endo-116-6-2293 · Cited by 239
Divergent evolution of fucosyltransferase genes from vertebrates, invertebrates, and bacteria
Oriol, R., Mollicone, R., Cailleau, A., Balanzino, L., & Breton, C. (1999) · Glycobiology · doi:10.1093/glycob/9.4.323 · Cited by 237
Chemistry of Lipid A: At the Heart of Innate Immunity
Molinaro, A., Holst, O., Di Lorenzo, F., Callaghan, M., Nurisso, A., D'Errico, G., Zamyatina, A., Peri, F., Berisio, R., Jerala, R., et al. (2015) · Chemistry – A European Journal · doi:10.1002/chem.201403923 · Cited by 235
The Sialome—Far More Than the Sum of Its Parts
Cohen, M., & Varki, A. (2010) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2009.0148 · Cited by 232
Oki, S., Chiba, A., Yamamura, T., & Miyake, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420862 · Cited by 232
O-GlcNAcylation regulates EZH2 protein stability and function
Chu, C.-S., Lo, P.-W., Yeh, Y.-H., Hsu, P.-H., Peng, S.-H., Teng, Y.-C., Kang, M.-L., Wong, C.-H., & Juan, L.-J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323226111 · Cited by 231
Self-citationGeneration of monoclonal antibodies reacting with normal and cancer cells of human breast.
Ménard, S., Tagliabue, E., Canevari, S., Fossati, G., & COLNAGHI, M. I. (1983) · PubMed · Cited by 231
Asano, K., Takahashi, N., Ushiki, M., Monya, M., Aihara, F., Kuboki, E., Moriyama, S., Iida, M., Kitamura, H., Qiu, C.-H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8802 · Cited by 231
Galectins and Immune Responses—Just How Do They Do Those Things They Do?
Thiemann, S., & Baum, L. G. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055402 · Cited by 230
Organizing multivalency in carbohydrate recognition
Müller, C., Despras, G., & Lindhorst, T. K. (2016) · Chem. Soc. Rev. · doi:10.1039/c6cs00165c · Cited by 230
Signaling by Antibodies: Recent Progress
Bournazos, S., Wang, T. T., Dahan, R., Maamary, J., & Ravetch, J. V. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052433 · Cited by 229
Cancer vaccines and carbohydrate epitopes
Heimburg-Molinaro, J., Lum, M., Vijay, G., Jain, M., Almogren, A., & Rittenhouse-Olson, K. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.009 · Cited by 227
Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38251 · Cited by 226
Glypicans in growth control and cancer
Filmus, J. (2001) · Glycobiology · doi:10.1093/glycob/11.3.19r · Cited by 226
Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225
Development of Globo-H Cancer Vaccine
Danishefsky, S. J., Shue, Y., Chang, M. N. T., & Wong, C. (2015) · Accounts of Chemical Research · doi:10.1021/ar5004187 · Cited by 224
Self-citationSite-Specific Antibody–Drug Conjugation through Glycoengineering
Zhou, Q., Stefano, J. E., Manning, C., Kyazike, J., Chen, B., Gianolio, D. A., Park, A., Busch, M., Bird, J., Zheng, X., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400505q · Cited by 223
Monophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions
Ulrich, J. T., & Myers, K. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_21 · Cited by 222
In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity
Thomann, M., Schlothauer, T., Dashivets, T., Malik, S., Avenal, C., Bulau, P., Rüger, P., & Reusch, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134949 · Cited by 220
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
Avery, O. T., & Goebel, W. F. (1931) · Journal of Experimental Medicine · doi:10.1084/jem.54.3.437 · Cited by 220
Glucosylceramide synthase and glycosphingolipid synthesis
Ichikawa, S., & Hirabayashi, Y. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01249-5 · Cited by 219
Lund, J., Takahashi, N., Pound, J. D., Goodall, M., & Jefferis, R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4963 · Cited by 216
Seeberger, P. H. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01210 · Cited by 213
Marketing approval of mogamulizumab: A triumph for glyco-engineering
Beck, A., & Reichert, J. M. (2012) · mAbs · doi:10.4161/mabs.20996 · Cited by 211
The design of semi-synthetic and synthetic glycoconjugate vaccines
Costantino, P., Rappuoli, R., & Berti, F. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.609554 · Cited by 210
Physical and Chemical Studies on Ceruloplasmin
Morell, A. G., Van Den Hamer, C. J. A., Scheinberg, I. H., & Ashwell, G. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99835-2 · Cited by 209
Immunomodulatory properties of the vaccine adjuvant alum
Oleszycka, E., & Lavelle, E. C. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.007 · Cited by 207
The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
Huszczynski, S. M., Lam, J. S., & Khursigara, C. M. (2019) · Pathogens · doi:10.3390/pathogens9010006 · Cited by 207
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
Ragupathi, G., Gardner, J. R., Livingston, P. O., & Gin, D. Y. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.18 · Cited by 206
Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results
Cluff, C. W. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1603-7_10 · Cited by 205
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
Ikehara, Y., Ikehara, S. K., & Paulson, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403538200 · Cited by 203
A common glycan structure on immunoglobulin G for enhancement of effector functions
Lin, C.-W., Tsai, M.-H., Li, S.-T., Tsai, T.-I., Chu, K.-C., Liu, Y.-C., Lai, M.-Y., Wu, C.-Y., Tseng, Y.-C., Shivatare, S. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513456112 · Cited by 200
Self-citationThe signaling mechanisms of syndecan heparan sulfate proteoglycans
Lambaerts, K., Wilcox-Adelman, S. A., & Zimmermann, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.05.002 · Cited by 199
Tools for Glycomics: Mapping Interactions of Carbohydrates in Biological Systems
Ratner, D. M., Adams, E. W., Disney, M. D., & Seeberger, P. H. (2004) · ChemBioChem · doi:10.1002/cbic.200400106 · Cited by 198
CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
Clark, E. A., & Giltiay, N. V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02235 · Cited by 197
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity
Marciani, D. J., Press, J. B., Reynolds, R. C., Pathak, A. K., Pathak, V., Gundy, L. E., Farmer, J. T., Koratich, M. S., & May, R. D. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00118-3 · Cited by 196
Review: Current and new generation pneumococcal vaccines
Feldman, C., & Anderson, R. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.06.006 · Cited by 196
Wakankar, A. A., Feeney, M. B., Rivera, J., Chen, Y., Kim, M., Sharma, V. K., & Wang, Y. J. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900434c · Cited by 195
Immunology and efficacy of MF59-adjuvanted vaccines
Ko, E.-J., & Kang, S.-M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1495301 · Cited by 194
New hepatitis B vaccine formulated with an improved adjuvant system
Kundi, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.133 · Cited by 193
Endotoxins: Lipopolysaccharides of Gram-Negative Bacteria
Wang, X., & Quinn, P. J. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-9078-2_1 · Cited by 192
Recent insights into the biological roles of mucin-type O-glycosylation
Tian, E., & Ten Hagen, K. G. (2009) · Glycoconjugate Journal · doi:10.1007/s10719-008-9162-4 · Cited by 191
Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S.-C., Scragg, I. G., & Dwek, R. A. (1997) · Biochemistry · doi:10.1021/bi9621472 · Cited by 191
Pozsgay, V., Chu, C., Pannell, L., Wolfe, J., Robbins, J. B., & Schneerson, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5194 · Cited by 191
Anatomy of CD1–lipid antigen complexes
Moody, D. B., Zajonc, D. M., & Wilson, I. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1605 · Cited by 190
Alexander, J., del Guercio, M.-F., Maewal, A., Qiao, L., Fikes, J., Chesnut, R. W., Paulson, J., Bundle, D. R., DeFrees, S., & Sette, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1625 · Cited by 188
The role of galectins in the initiation, amplification and resolution of the inflammatory response
Rubinstein, N., Ilarregui, J. M., Toscano, M. A., & Rabinovich, G. A. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00278.x · Cited by 188
Soltysik, S., Wu, J.-Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., & Kensil, C. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00077-e · Cited by 188
den Haan, J. M. M., Arens, R., & van Zelm, M. C. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.011 · Cited by 185
Rajeev, K. G., Nair, J. K., Jayaraman, M., Charisse, K., Taneja, N., O'Shea, J., Willoughby, J. L. S., Yucius, K., Nguyen, T., Shulga‐Morskaya, S., et al. (2015) · ChemBioChem · doi:10.1002/cbic.201500023 · Cited by 185
Development of orally active inhibitors of protein and cellular fucosylation
Okeley, N. M., Alley, S. C., Anderson, M. E., Boursalian, T. E., Burke, P. J., Emmerton, K. M., Jeffrey, S. C., Klussman, K., Law, C.-L., Sussman, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222263110 · Cited by 184
Vaccines based on the cell surface carbohydrates of pathogenic bacteria
Jones, C. (2005) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652005000200009 · Cited by 184
In Vivo Synthesis of Mammalian-Like, Hybrid-Type N-Glycans in Pichia pastoris
Vervecken, W., Kaigorodov, V., Callewaert, N., Geysens, S., De Vusser, K., & Contreras, R. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.5.2639-2646.2004 · Cited by 184
Physical and Chemical Studies on Ceruloplasmin
van den Hamer, C. J. A., Morell, A. G., Scheinberg, I. H., Hickman, J., & Ashwell, G. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)63808-1 · Cited by 183
Advances in silica based nanoparticles for targeted cancer therapy
Yang, Y., & Yu, C. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.018 · Cited by 183
Meier, M., Bider, M. D., Malashkevich, V. N., Spiess, M., & Burkhard, P. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3853 · Cited by 182
A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens
Snapper, C. M., & Mond, J. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2229 · Cited by 181
MHC Class II Antigen Presentation by Dendritic Cells Regulated through Endosomal Sorting
ten Broeke, T., Wubbolts, R., & Stoorvogel, W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016873 · Cited by 181
Glycoconjugate glycans as viral receptors
Olofsson, S., & Bergström, T. (2005) · Annals of Medicine · doi:10.1080/07853890510007340 · Cited by 181
Ragupathi, G., Koide, F., Livingston, P. O., Cho, Y. S., Endo, A., Wan, Q., Spassova, M. K., Keding, S. J., Allen, J. R., Ouerfelli, O., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057244+ · Cited by 178
Lifely, M. R., Hale, C., Boyce, S., Keen, M. J., & Phillips, J. (1995) · Glycobiology · doi:10.1093/glycob/5.8.813 · Cited by 178
Traveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Synthesis, Processing, and Function of N-glycans in N-glycoproteins
Bieberich, E. (2014) · Advances in Neurobiology · doi:10.1007/978-1-4939-1154-7_3 · Cited by 177
Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection
Sewald, X., Ladinsky, M. S., Uchil, P. D., Beloor, J., Pi, R., Herrmann, C., Motamedi, N., Murooka, T. T., Brehm, M. A., Greiner, D. L., et al. (2015) · Science · doi:10.1126/science.aab2749 · Cited by 177
Recent advances of antibody drug conjugates for clinical applications
Zhao, P., Zhang, Y., Li, W., Jeanty, C., Xiang, G., & Dong, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.012 · Cited by 176
Three-Dimensional Elution Mapping of Pyridylaminated N-Linked Neutral and Sialyl Oligosaccharides
Takahashi, N., Nakagawa, H., Fujikawa, K., Kawamura, Y., & Tomiya, N. (1995) · Analytical Biochemistry · doi:10.1006/abio.1995.1201 · Cited by 175
Multi-receptor detection of individual bacterial products by the innate immune system
Kieser, K. J., & Kagan, J. C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.25 · Cited by 175
Synthetic carbohydrate-based vaccines: challenges and opportunities
Mettu, R., Chen, C.-Y., & Wu, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0591-0 · Cited by 173
Glycoproteomic Analysis of Antibodies
Zauner, G., Selman, M. H. J., Bondt, A., Rombouts, Y., Blank, D., Deelder, A. M., & Wuhrer, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.026005 · Cited by 172
Slovin, S. F., Ragupathi, G., Musselli, C., Olkiewicz, K., Verbel, D., Kuduk, S. D., Schwarz, J. B., Sames, D., Danishefsky, S., Livingston, P. O., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.112 · Cited by 171
Production of therapeutic antibodies with controlled fucosylation
Yamane-Ohnuki, N., & Satoh, M. (2009) · mAbs · doi:10.4161/mabs.1.3.8328 · Cited by 170
Chang, W.-W., Lee, C. H., Lee, P., Lin, J., Hsu, C.-W., Hung, J.-T., Lin, J.-J., Yu, J.-C., Shao, L.-E., Yu, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804979105 · Cited by 169
Self-citationRole of Protein Glycosylation in Host-Pathogen Interaction
Lin, B., Qing, X., Liao, J., & Zhuo, K. (2020) · Cells · doi:10.3390/cells9041022 · Cited by 169
Renukaradhya, G. J., Khan, M. A., Vieira, M., Du, W., Gervay-Hague, J., & Brutkiewicz, R. R. (2008) · Blood · doi:10.1182/blood-2007-05-092866 · Cited by 168
Chemical Biology Approaches to Designing Defined Carbohydrate Vaccines
Anish, C., Schumann, B., Pereira, C. L., & Seeberger, P. H. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.002 · Cited by 167
The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling
Cochet, F., & Peri, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112318 · Cited by 166
Methods in Enzymology: O‐Glycosylation of Proteins
Peter‐Katalinić, J. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)05007-x · Cited by 164
Chemical and Chemoenzymatic Synthesis of Glycoproteins for Deciphering Functions
Wang, L.-X., & Amin, M. N. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.001 · Cited by 163
Cancer-associated carbohydrates identified by monoclonal antibodies
Sell, S. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90250-9 · Cited by 162
A single glycan on IgE is indispensable for initiation of anaphylaxis
Shade, K.-T., Platzer, B., Washburn, N., Mani, V., Bartsch, Y. C., Conroy, M. E., Pagan, J. D., Bosques, C. J., Mempel, T. R., Fiebiger, E., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142182 · Cited by 162
Abeyrathne, P. D., Daniels, C. E., Poon, K., Matewish, M. J., & Lam, J. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.9.3002-3012.2005 · Cited by 162
Sialidases from gut bacteria: a mini-review
Juge, N., Tailford, L., & Owen, C. D. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150226 · Cited by 162
Silva, M., Videira, P. A., & Sackstein, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01878 · Cited by 162
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer
Huang, Y.-L., Hung, J.-T., Cheung, S. K. C., Lee, H.-Y., Chu, K.-C., Li, S.-T., Lin, Y.-C., Ren, C.-T., Cheng, T.-J. R., Hsu, T.-L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222649110 · Cited by 161
Self-citationThe Role of Glycosphingolipids in Immune Cell Functions
Zhang, T., de Waard, A. A., Wuhrer, M., & Spaapen, R. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00090 · Cited by 160
Yamamoto, N., Tanabe, Y., Okamoto, R., Dawson, P. E., & Kajihara, Y. (2008) · Journal of the American Chemical Society · doi:10.1021/ja072543f · Cited by 159
Li, X., Fang, T., & Boons, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402606 · Cited by 159
Yang, X., lyer, A. K., Singh, A., Choy, E., Hornicek, F. J., Amiji, M. M., & Duan, Z. (2015) · Scientific Reports · doi:10.1038/srep08509 · Cited by 158
Imai-Nishiya (2007) · doi:10.1186/1472-6750-7-84 · Cited by 157
Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins
Zhang, F., Liu, M.-R., & Wan, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00661 · Cited by 157
Carbohydrate-based immune adjuvants
Petrovsky, N., & Cooper, P. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.30 · Cited by 157
Current Status: Site-Specific Antibody Drug Conjugates
Schumacher, D., Hackenberger, C. P. R., Leonhardt, H., & Helma, J. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0265-6 · Cited by 157
Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
Working, P. K., & Dayan, A. D. (1996) · PubMed · Cited by 156
The Immunobiology of Toll-Like Receptor 4 Agonists: From Endotoxin Tolerance to Immunoadjuvants
Bohannon, J. K., Hernandez, A., Enkhbaatar, P., Adams, W. L., & Sherwood, E. R. (2013) · Shock · doi:10.1097/shk.0000000000000042 · Cited by 154
Yamaguchi, Y. (2001) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0238 · Cited by 154
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Parsons, T. B., Struwe, W. B., Gault, J., Yamamoto, K., Taylor, T. A., Raj, R., Wals, K., Mohammed, S., Robinson, C. V., Benesch, J. L. P., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201508723 · Cited by 153
Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy
Sun, J., Qiao, L., Sanmamed, M. F., & Wang, J. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2925 · Cited by 151
Regulation of Notch signaling by glycosylation
Stanley, P. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.09.007 · Cited by 150
Agius, M. A., Kłodowska-Duda, G. A., Maciejowski, M., Potemkowski, A., Li, J., Patra, K., Wesley, J. B., Madani, S., Barron, G., Katz, E., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517740641 · Cited by 150
Glycoengineering of Antibodies for Modulating Functions
Wang, L., Tong, X., Li, C., Giddens, J. P., & Li, T. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012911 · Cited by 148
Emerging methods for the production of homogeneous human glycoproteins
Rich, J. R., & Withers, S. G. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.148 · Cited by 147
Glycobiology simplified: diverse roles of glycan recognition in inflammation
Schnaar, R. L. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0116-021r · Cited by 147
Parmar, R. G., Willoughby, J. L. S., Liu, J., Foster, D. J., Brigham, B., Theile, C. S., Charissé, K., Akinc, A., Guidry, E. N., Pei, Y., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600130 · Cited by 146
Progress in understanding the assembly process of bacterial O-antigen
Kalynych, S., Morona, R., & Cygler, M. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12070 · Cited by 145
Huang, M. L., Smith, R. A. A., Trieger, G. W., & Godula, K. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505012a · Cited by 145
Grewal, P. K. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)79013-3 · Cited by 143
Galectin-8-N-domain Recognition Mechanism for Sialylated and Sulfated Glycans
Ideo, H., Matsuzaka, T., Nonaka, T., Seko, A., & Yamashita, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195925 · Cited by 142
Current methods for the synthesis of homogeneous antibody–drug conjugates
Sochaj, A. M., Świderska, K. W., & Otlewski, J. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.001 · Cited by 142
Glycosphingolipid FunctionsPreprint
Lingwood, C. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004788 · Cited by 142
Glycodelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins
Meuris, L., Santens, F., Elson, G., Festjens, N., Boone, M., Dos Santos, A., Devos, S., Rousseau, F., Plets, E., Houthuys, E., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2885 · Cited by 141
Dziadek, S., Hobel, A., Schmitt, E., & Kunz, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501594 · Cited by 141
Chiba, Y., Suzuki, M., Yoshida, S., Yoshida, A., Ikenaga, H., Takeuchi, M., Jigami, Y., & Ichishima, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26298 · Cited by 140
Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds
Astronomo, R. D., Kaltgrad, E., Udit, A. K., Wang, S., Doores, K. J., Huang, C., Pantophlet, R. A., Paulson, J. C., Wong, C., Finn, M. G., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.012 · Cited by 139
Self-citationThe HIV glycan shield as a target for broadly neutralizing antibodies
Doores, K. J. (2015) · FEBS Journal · doi:10.1111/febs.13530 · Cited by 139
Totsika, M., Kostakioti, M., Hannan, T. J., Upton, M., Beatson, S. A., Janetka, J. W., Hultgren, S. J., & Schembri, M. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit245 · Cited by 139
Persistence of Antibodies in Human Subjects Injected with Pneumococcal Polysaccharides
Heidelberger, M., DiLapi, M. M., Siegel, M., & Walter, A. W. (1950) · The Journal of Immunology · doi:10.4049/jimmunol.65.5.535 · Cited by 138
Sugar-Assisted Glycopeptide Ligation
Brik, A., Yang, Y., Ficht, S., & Wong, C. (2006) · Journal of the American Chemical Society · doi:10.1021/ja061165w · Cited by 138
Self-citationEmerging Technologies for Making Glycan-Defined Glycoproteins
Wang, L., & Lomino, J. V. (2011) · ACS Chemical Biology · doi:10.1021/cb200429n · Cited by 138
Ni, J., Song, H., Wang, Y., Stamatos, N. M., & Wang, L. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0502816 · Cited by 138
Initial Step of Virus Entry: Virion Binding to Cell-Surface Glycans
Koehler, M., Delguste, M., Sieben, C., Gillet, L., & Alsteens, D. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-122019-070025 · Cited by 138
Lo‐Man, R., Vichier‐Guerre, S., Perraut, R., Dériaud, E., Huteau, V., BenMohamed, L., Diop, O. M., Livingston, P. O., Bay, S., & Leclerc, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0252 · Cited by 136
Galectins as Molecular Targets for Therapeutic Intervention
Dings, R. P. M., Miller, M. C., Griffin, R. J., & Mayo, K. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030905 · Cited by 136
Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
Cui, H., Zhu, X., Li, S., Wang, P., & Fang, J. (2021) · ACS Omega · doi:10.1021/acsomega.1c01755 · Cited by 135
Semisynthesis of a Homogeneous Glycoprotein Enzyme: Ribonuclease C: Part 2
Piontek, C., Silva, D. V., Heinlein, C., Pöhner, C., Mezzato, S., Ring, P., Martin, A., Schmid, F. X., & Unverzagt, C. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200804735 · Cited by 134
Developments in Carbohydrate-Based Cancer Therapeutics
Hossain, F., & Andreana, P. R. (2019) · Pharmaceuticals · doi:10.3390/ph12020084 · Cited by 134
The regulatory power of glycans and their binding partners in immunity
Johnson, J. L., Jones, M. B., Ryan, S. O., & Cobb, B. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.006 · Cited by 133
McConville, M. J., & Menon, A. K. (2000) · Molecular Membrane Biology · doi:10.1080/096876800294443 · Cited by 133
Vaccination with Theratope® (STn-KLH) as treatment for breast cancer
Holmberg, L., & Sandmaier, B. M. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.6.655 · Cited by 133
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation
Bochner, B. S., & Zimmermann, N. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.031 · Cited by 132
Gangliosides as High Affinity Receptors for Tetanus Neurotoxin
Chen, C., Fu, Z., Kim, J. P., Barbieri, J. T., & Baldwin, M. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027391 · Cited by 132
Douaiher, J., Succar, J., Lancerotto, L., Gurish, M. F., Orgill, D. P., Hamilton, M. J., Krilis, S. A., & Stevens, R. L. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00006-7 · Cited by 131
Kanda, Y., Imai, H., Kuni‐Kamochi, R., Mori, K., Inoue, M., Kitajima-Miyama, K., Okazaki, A., Iida, S., Shitara, K., & Satoh, M. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.04.025 · Cited by 131
Kaiser, A., Gaidzik, N., Becker, T., Menge, C., Groh, K., Cai, H., Li, Y., Gerlitzki, B., Schmitt, E., & Kunz, H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000462 · Cited by 131
Glycan–protein interactions in viral pathogenesis
Raman, R., Tharakaraman, K., Sasisekharan, V., & Sasisekharan, R. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.10.003 · Cited by 131
Joyce, J. G., Krauss, I. J., Song, H. C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807837105 · Cited by 129
Kudryashov, V., Glunz, P. W., Williams, L. J., Hintermann, S., Danishefsky, S. J., & Lloyd, K. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051623598 · Cited by 128
The leucine zipper domain controls the orientation of AP-1 in the NFAT·AP-1·DNA complex
Erlanson, D. A., Chytil, M., & Verdine, G. L. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90165-9 · Cited by 128
Huang, H.-Y., Liao, H.-Y., Chen, X., Wang, S.-W., Cheng, C.-W., Shahed-Al-Mahmud, M., Liu, Y.-M., Mohapatra, A., Chen, T.-H., Lo, J. M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm0899 · Cited by 128
Self-citationWang, J., Li, H., Zou, G., & Wang, L. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b702961f · Cited by 127
Silva, R. A. D., Wang, Q., Chidley, T., Appulage, D. K., & Andreana, P. R. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902607a · Cited by 127
Brozek, K. A., & Raetz, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55412-0 · Cited by 126
Specificity in cancer immunotherapy
Schietinger, A., Philip, M., & Schreiber, H. W. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.07.001 · Cited by 126
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
Ferreira, I. G., Pucci, M., Venturi, G., Malagolini, N., Chiricolo, M., & Dall’Olio, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020580 · Cited by 126
Wang, L., Ni, J., Singh, S., & Li, H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.12.020 · Cited by 125
Li, T., Tong, X., Yang, Q., Giddens, J. P., & Wang, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738765 · Cited by 125
Viewing Siglecs through the lens of tumor immunology
Fraschilla, I. R., & Pillai, S. S. (2017) · Immunological Reviews · doi:10.1111/imr.12526 · Cited by 125
Site-Specific Antibody Conjugation for ADC and Beyond
Zhou, Q. (2017) · Biomedicines · doi:10.3390/biomedicines5040064 · Cited by 125
Recent Development in Carbohydrate Based Anticancer Vaccines
Yin, Z., & Huang, X. (2012) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2012.659364 · Cited by 124
Evolving Strategies for Protein Synthesis Converge on Native Chemical Ligation
Macmillan, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602945 · Cited by 123
Norgard-Sumnicht, K., & Varki, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12012 · Cited by 123
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
Liu, Y., Cao, W., Sun, M., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1713707 · Cited by 123
Recent Developments in Synthetic Carbohydrate‐Based Diagnostics, Vaccines, and Therapeutics
Fernández‐Tejada, A., Cañada, F. J., & Jiménez‐Barbero, J. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500831 · Cited by 120
Metabolic Engineering of Monoclonal Antibody Carbohydrates for Antibody–Drug Conjugation
Okeley, N. M., Toki, B. E., Zhang, X., Jeffrey, S. C., Burke, P., Alley, S. C., & Senter, P. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc4002695 · Cited by 120
New trends in carbohydrate-based vaccines
Roy, R. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.10.005 · Cited by 120
Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
Yen, H.-Y., Liu, Y.-C., Chen, N.-Y., Tsai, C.-F., Wang, Y.-T., Chen, Y.-J., Hsu, T.-L., Yang, P.-C., & Wong, C.-H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507329112 · Cited by 119
Self-citationAgonistic CD40 Antibodies in Cancer Treatment
Djureinovic, D., Wang, M., & Kluger, H. M. (2021) · Cancers · doi:10.3390/cancers13061302 · Cited by 119
DebRoy, C., Fratamico, P. M., Yan, X., Baranzoni, G. M., Liu, Y., Needleman, D. S., Tebbs, R. S., O’Connell, C. D., Allred, A. F., Swimley, M. S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147434 · Cited by 118
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
Yao, G., Zhang, S., Mahrhold, S., Lam, K. H., Stern, D., Bagramyan, K. A., Perry, K., Kalkum, M., Rummel, A., Dong, M., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3245 · Cited by 118
Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery
Miller, T., Goude, M. C., McDevitt, T. C., & Temenoff, J. S. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.09.039 · Cited by 116
Wang, Q., Zhou, Z., Tang, S., & Guo, Z. (2011) · ACS Chemical Biology · doi:10.1021/cb200358r · Cited by 116
Slovin, S. F., Ragupathi, G., Musselli, C., Fernandez, C., Diani, M., Verbel, D., Danishefsky, S. J., Livingston, P. O., & Scher, H. I. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0598-5 · Cited by 116
Galactose‐modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
Aspeslagh, S., Li, Y., Yu, E. D., Pauwels, N., Trappeniers, M., Girardi, E., Decruy, T., Beneden, K. V., Venken, K., Drennan, M. B., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.145 · Cited by 115
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998–2006)
Kafeja, F., Beutels, P., & Damme, P. V. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.032 · Cited by 115
Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody
Krauss, I. J., Joyce, J. G., Finnefrock, A. C., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074804r · Cited by 114
Regulation of antibody effector functions through IgG Fc N-glycosylation
Quast, I., Peschke, B., & Lünemann, J. D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2366-z · Cited by 114
Renaudet, O., BenMohamed, L., Dasgupta, G., Bettahi, I., & Dumy, P. (2008) · ChemMedChem · doi:10.1002/cmdc.200700315 · Cited by 113
Lenza, M. P., Oyenarte, I., Diercks, T., Quintana, J. I., Gimeno, A., Coelho, H., Diniz, A., Peccati, F., Delgado, S., Bosch, A., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202011015 · Cited by 113
Westerlind, U., Hobel, A., Gaidzik, N., Schmitt, E., & Kunz, H. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802102 · Cited by 112
Clark, M. C., & Baum, L. G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06304.x · Cited by 112
Tang, F., Wang, L., & Huang, W. (2017) · Nature Protocols · doi:10.1038/nprot.2017.058 · Cited by 112
Miller, G. M., & Hsieh‐Wilson, L. C. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.08.015 · Cited by 111
Lo‐Man, R., Vichier‐Guerre, S., Bay, S., Dériaud, E., Cantacuzène, D., & Leclerc, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2849 · Cited by 110
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
Doores, K. J., Fulton, Z., Hong, V., Patel, M. K., Scanlan, C. N., Wormald, M. R., Finn, M. G., Burton, D. R., Wilson, I. A., & Davis, B. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002717107 · Cited by 110
Allen, J. R., Harris, C. R., & Danishefsky, S. J. (2001) · Journal of the American Chemical Society · doi:10.1021/ja002779i · Cited by 110
Metadata
- Authors
- Shivatare, S. S., Shivatare, V. S., & Wong, C.-H.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-09-29
- Volume
- 122
- Issue
- 20
- Pages
- 15603-15671
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W4297983532
- Cited by
- 257
- References
- 608
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.